Real-time testing for Helicobacter pylori and atrophy of the gastric body: Reply to the editorial of D. Graham [1]

Endoscopy

Volumn 38, Issue 3, 2006, Pages 285-286

  Tucci, Ant ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Azienda USL di Bologna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; STOMACH SECRETION INHIBITOR;

ATROPHIC GASTRITIS; BACTERIUM CULTURE; DEVICE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; LETTER; PH MEASUREMENT; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; STOMACH ADENOCARCINOMA; STOMACH PH; UREA BREATH TEST;

DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 33645065851     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925209     Document Type: Letter

References (23)

1. Graham DY. Is real-time testing for Helicobacter pylori and corpus atrophy clinically useful in 2005? Endoscopy 2005; 37: 1006-1007
2. Tucci A, Tucci P, Bisceglia Met al. Real-time detection of Helicobacter pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopy. Endoscopy 2005; 37: 966-976
3. Belair PA, Metz DC, Faigel DO, Furth EE. Receiver operator characteristic analysis of endoscopy as a test for gastritis. Dig Dis Sci 1997; 42: 2227-2233
4. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995; 108: 917-924
5. Toth E, Sjolund K, Fork FT, Lindstrom C. Chronic atrophic fundic gastritis diagnosed by a modified Congo red test. Endoscopy. 1995; 27: 654-658
6. Ricci C, Vakil N, Rugge Met al. Serological markers for atrophic gastritis in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004; 99: 1-6
7. Vaananen H, Vauhkonen M, Helske Tet al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen 1: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-891
8. Lindgren A, Lindgren A, Lindstedt G. Advantages of serum pepsinogen A combined with gastrin or pepsinogen C as first-line analytes in the evaluation of suspected cobalamin deficiency: a study in patients previously not subjected to gastrointestinal surgery. J Int Med 1998; 244: 341-349
9. Sanduleanu S, Bruine AD, Biemond Iet al. Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. Eur J Clin Invest 2003; 33: 147-154
10. Furuta T, ElOmar EM, Xiao Fet al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92-105
11. Annibale B, Capurso G, Lahner Eet al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 2003; 52: 496-501
12. Farinati F, Cardin F, Di Mario Fet al. Perendoscopic gastric pH determination. Simple method for increasing accuracy in diagnosing chronic atrophic gastritis. Gastrointest Endosc 1987; 33: 293-297
13. Jaskiewicz K, Van Helden PD, Wiid IJet al. Chronic atrophic gastritis, gastric pH, nitrites and micronutrient levels in a population at risk for gastric carcinoma. Anticancer Res 1990; 10: 833-836
14. Andersen J, Strom M. A technique for screening of achlorhydria and hypochlorhydria during upper gastrointestinal endoscopy. Scand J Gastroenterol 1990; 25: 1084-1088
15. Segawa K, Nakazawa S, Tsukamoto Yet al. Estimate of gastric acid output by evaluation of fasting gastric juice collected endoscopically. Hepatogastroenterology 1991; 38 (Suppl 1): 9-82
16. Kamada T, Hata J, Sugiu Ket al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005; 21: 1121-1126
17. Uemura N, Okamoto S, Yamamoto Set al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 829-832
18. Ohata H, Kitauchi S, Yoshimura Net al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-143
19. Annibale B, Azzoni C, Corleto VDet al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Hepatol Gastroenterol 2001; 13: 1449-1456
20. Bordi C. Endocrine tumours of the stomach. Pathol Res Pract 1995; 191: 373-380
21. Lahner E, Caruana P, D'Ambra Get al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc 2001; 53: 443-448
22. Malfertheiner P, Megraud F, O'Morain Cet al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
23. Satoh K. Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research. J Gastroenterol 2002; 37 (Suppl 13): 34-38